In the current study, we demonstrated that colchicine protected peri-aortic CaPO4 injury- and subcutaneous Ang-II infusion-induced murine AAA development by inhibiting vascular SMC phenotype switching, SMC apoptosis, and vascular inflammation. Here, AGT is linked to triple-A syndrome.